Chinese companies under stricter review which is good for transparency and accountibility, anticipate short-term disruption to market sentiments. However, this changes the long-term positive growth outlook of China and its giant establishments to scale up to the world.
In long term, such clampdown will make such chinese tech firms more robust and structurally sound, if it is initiated by Biden, it could be much worst off and the afterall Chinese govt will not make these homegrown techs go bust...
The sleeping giant is roaring to life again. Stagnant since starting of hk riot...Share buy back and instantly 12 plus % gain..big gap to reach past glory...
Seems to be going up a little small bit last few days .. Let's see how it performs coming days.. Only up some more cents will entice majority to take up the rights...
J & J seems to generate mostly bad news, tainted by a scandal related to its talcum-based baby power, covid vaccine can develope blood clots, why others are generating income from vaccination, they are busy with court case?
Drug distributors, J&J to announce $26 bln opioid settlement this week - source
Felt was oversold. At this price, worth to gradually pick up this stock for long term and opportunity, hopefully wait for it to secure more govt contracts and grow into a healthcare powerhouse. Lock down period has ended, we should start seeing positive news and more institutions buying it.